NasdaqGS:HSICHealthcare
Should Henry Schein’s (HSIC) CEO Transition Amid Flat Organic Growth Require Action From Investors?
Henry Schein recently announced that Fedd Lowery will succeed long-time CEO Stanley Bergman in March, following two years of flat organic revenue growth.
This leadership change comes at a time when questions are intensifying over whether the company can accelerate growth without leaning more heavily on acquisitions.
We’ll now examine how the CEO transition amid stagnant organic revenue growth may influence Henry Schein’s existing investment narrative and outlook.
Find 54 companies with...